IGFBP6 and myelofibrosis: In this complex scenario, our recent work demonstrated that IGFBP-6/SHH/Toll-like receptor4 axis is implicated in alterations of the primary myelofibrosis microenvironment and that IGFBP-6 may play a central role in activating the SHH pathway during the fibrotic process [58].